Naples, Italy

Maria Teresa Masucci


Average Co-Inventor Count = 21.0

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Napoli, IT (1999)
  • Naples, IT (2001)

Company Filing History:


Years Active: 1999-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Maria Teresa Masucci: Innovator in Urokinase-type Plasminogen Activator Research

Introduction

Maria Teresa Masucci is a prominent inventor based in Naples, Italy. She has made significant contributions to the field of medical research, particularly in the area of urokinase-type plasminogen activator receptors. With a total of 2 patents, her work has implications for understanding and treating various medical conditions.

Latest Patents

Her latest patents include innovative methods related to the inhibition of plasminogen activation. The first patent focuses on the activation of plasminogen to plasmin being inhibited by preventing the binding of a receptor binding form of urokinase-type plasminogen activator to a urokinase-type plasminogen activator receptor in mammals. This method effectively prevents the conversion of plasminogen into plasmin. The second patent provides DNA fragments that encode for soluble, active fragments of the urokinase-type plasminogen activator receptor, further advancing the understanding of this critical biological process.

Career Highlights

Maria Teresa Masucci is associated with Cancerforskningsfondet Af 1989, where she continues her research and development efforts. Her work has been instrumental in advancing the scientific community's knowledge of plasminogen activation and its implications for cancer research.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Francesco Blasi and Ann Louring Roldan. These partnerships have enriched her research and contributed to the success of her innovative projects.

Conclusion

Maria Teresa Masucci stands out as a key figure in the field of urokinase-type plasminogen activator research. Her patents and collaborative efforts reflect her commitment to advancing medical science and improving therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…